Transcriptomics

Dataset Information

0

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients


ABSTRACT: Molecular targeted therapy has shown potential in hepatocellular carcinoma (HCC) patients, and immunotherapy applications are developing rapidly. However, clinical guidance for making individualized therapy decisions for HCC patients remains lacking. To facilitate individualized and reasonable clinical guidance for each HCC patient, we constructed the MDH score.

ORGANISM(S): Homo sapiens

PROVIDER: GSE213615 | GEO | 2022/09/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA881935 | ENA
2023-10-01 | GSE232331 | GEO
2014-06-10 | GSE45684 | GEO
| PRJNA515545 | ENA
| PRJNA515546 | ENA
2014-06-10 | E-GEOD-45684 | biostudies-arrayexpress
2016-12-28 | GSE92928 | GEO
2015-04-17 | GSE67979 | GEO
2019-05-25 | GSE81866 | GEO
2016-04-26 | GSE80641 | GEO